-
EP4173619
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4173619
| EP4173619 - NEW ACETAMINOPHEN COMPOUND COMPOSITION WITHOUT SIDE EFFECT TO LIVER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 19.01.2024 Database last updated on 24.08.2024 | |
| Former | The application has been published Status updated on 31.03.2023 | Most recent event Tooltip | 19.01.2024 | The date on which the examining division becomes responsible, has been established | 19.01.2024 | Request for examination filed | published on 21.02.2024 [2024/08] | 19.01.2024 | Change - designated states | published on 21.02.2024 [2024/08] | Applicant(s) | For all designated states National Defense Education and Research Foundation P.O. Box 545 Neihu Taipei 11499 / TW | [2023/18] | Inventor(s) | 01 /
HU, Oliver Yao-Pu 11490 Taipei / TW | 02 /
SHIH, Tung-Yuan 11490 Taipei / TW | [2023/18] | Representative(s) | Straus, Alexander 2K Patent- und Rechtsanwälte Bajuwarenring 14 82041 Oberhaching / DE | [N/P] |
| Former [2023/18] | Straus, Alexander 2K Patent- und Rechtsanwälte - München Keltenring 9 82041 Oberhaching / DE | Application number, filing date | 22183582.0 | 13.11.2013 | [2023/18] | Previously filed application, date | WO2013CN87049 | 13.11.2013 | [2023/18] | Filing language | ZH | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4173619 | Date: | 03.05.2023 | Language: | EN | [2023/18] | Type: | A3 Search report | No.: | EP4173619 | Date: | 19.07.2023 | Language: | EN | [2023/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.06.2023 | Classification | IPC: | A61K31/167, A61K47/00, A61P1/16 | [2023/18] | CPC: |
A61K31/167 (EP,KR,US);
A61K31/165 (KR);
A61K31/765 (EP,KR,US);
A61K47/14 (US);
A61K47/36 (EP,KR,US);
A61K47/38 (EP,KR,US);
A61K47/46 (US);
A61K9/06 (KR);
A61K9/20 (KR);
A61K9/48 (KR);
A61P1/16 (EP,US);
A61P29/00 (EP,US);
A61P39/02 (EP,US);
A61K47/02 (EP,US);
A61K47/10 (EP,US);
A61K47/12 (EP,US);
A61K47/22 (EP,US);
A61K47/26 (EP,US);
A61K47/32 (EP,US)
(-)
| C-Set: |
A61K31/167, A61K2300/00 (EP,US);
A61K31/765, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/08] |
| Former [2023/18] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | NEUE ACETAMINOPHENVERBINDUNGSZUSAMMENSETZUNG OHNE NEBENWIRKUNGEN FÜR DIE LEBER | [2023/18] | English: | NEW ACETAMINOPHEN COMPOUND COMPOSITION WITHOUT SIDE EFFECT TO LIVER | [2023/18] | French: | NOUVELLE COMPOSITION D'UN COMPOSÉ D'ACÉTAMINOPHÈNE SANS EFFET SECONDAIRE POUR LE FOIE | [2023/18] | Examination procedure | 16.01.2024 | Amendment by applicant (claims and/or description) | 16.01.2024 | Examination requested [2024/08] | 16.01.2024 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP13897632.9 / EP3069733 | Fees paid | Renewal fee | 07.07.2022 | Renewal fee patent year 03 | 07.07.2022 | Renewal fee patent year 04 | 07.07.2022 | Renewal fee patent year 05 | 07.07.2022 | Renewal fee patent year 06 | 07.07.2022 | Renewal fee patent year 07 | 07.07.2022 | Renewal fee patent year 08 | 07.07.2022 | Renewal fee patent year 09 | 28.10.2022 | Renewal fee patent year 10 | 30.10.2023 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [T] - GANETSKY MICHAEL ET AL, "Effect of Excipients on Acetaminophen Metabolism and Its Implications for Prevention of Liver Injury", JOURNAL OF CLINICAL PHARMACOLOGY, (201304), vol. 53, no. 4, pages 413 - 420, XP002768260 [T] 1-6 * the whole document * DOI: http://dx.doi.org/10.1002/jcph.24 | [T] - AIDA KULO ET AL, "Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation", DARU JOURNAL OF PHARMACEUTICAL SCIENCES, BIOMED CENTRAL LTD, LONDON, UK, (20120719), vol. 20, no. 1, doi:10.1186/1560-8115-20-5, ISSN 2008-2231, page 5, XP021133843 [T] 1-6 * the whole document * DOI: http://dx.doi.org/10.1186/1560-8115-20-5 | [T] - THOMSEN MIKAEL S ET AL, "Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (Paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition", PHARMACOLOGY AND TOXICOLOGY, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, (19950101), vol. 76, no. 6, ISSN 0901-9928, pages 395 - 399, XP009193718 [T] 1-6 * the whole document * DOI: http://dx.doi.org/10.1111/j.1600-0773.1995.tb00168.x | [T] - HOJO M. ET AL, "Hepatotoxicity of acetaminophen and N -acetyl- p -benzoquinone imine and enhancement by fructose", XENOBIOTICA, UK, vol. 30, no. 9, doi:10.1080/004982500433345, ISSN 0049-8254, (20000122), pages 933 - 941, URL: http://dx.doi.org/10.1080/004982500433345, XP093029442 [T] 1-6 * Figures of the document * DOI: http://dx.doi.org/10.1080/004982500433345 |